Effects of the Integrated Grief Therapy on Psychological Resilience, Post-Traumatic Growth, Traum… (NCT07641270) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Effects of the Integrated Grief Therapy on Psychological Resilience, Post-Traumatic Growth, Traumatic Stress, and Grief Processes in Earthquake Survivors
This study evaluates the effectiveness of an Integrated Grief Therapy (IGT) group program for adults affected by the February 6, 2023 earthquake in Türkiye. Many earthquake survivors experience psychological difficulties such as traumatic stress, grief, and reduced resilience after losing loved ones, homes, and a sense of safety. This study aims to determine whether a structured group-based therapy program can help improve psychological well-being and reduce distress.
A total of 190 adult participants who experienced the earthquake were included in the study. Participants were randomly assigned to either an experimental group or a waitlist control group. The experimental group participated in an 8-session Integrated Grief Therapy program delivered face-to-face by trained mental health professionals. The program included psychoeducation about grief, emotional expression, cognitive and behavioral coping strategies, and activities designed to support meaning-making and adaptation after loss. The control group continued to receive routine psychosocial support services available in the community but did not participate in the structured therapy during the study period.
All participants completed standardized psychological assessments before and after the intervention. These assessments measured psychological resilience, post-traumatic growth, grief-related difficulties, and traumatic stress symptoms.
The study aims to determine whether participants who receive the Integrated Grief Therapy program show greater improvements in resilience and post-traumatic growth, and greater reductions in traumatic stress and grief symptoms, compared to those who do not receive the intervention during the same period.
The findings from this study may help inform the development of effective, scalable mental health interventions for individuals affected by large-scale disasters.
Who can participate
Age range
18 Years – 45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 to 45 years
* Individuals who were present in Hatay, Türkiye during the 2023 Türkiye-Syria earthquakes
* Individuals directly affected by the earthquake
* Ability to provide informed consent
* Willingness to participate in group-based psychological intervention sessions
Exclusion Criteria:
* Current diagnosis of a psychotic disorder or severe mental disorder
* Severe cognitive impairment or neurological condition
* Acute suicidal risk requiring immediate intervention or hospitalization
* Currently receiving intensive psychiatric or psychological treatment
* Substance use disorder in an acute or severe phase
* Inability to commit to attending the full intervention program
* Declined or withdrew informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is studying something called 'Integrated Grief Therapy' — can you explain what this type of therapy involves and how it differs from other grief or PTSD treatments I might already have access to?
2The trial is no longer recruiting, which means I couldn't join it — but based on what it's studying, like traumatic grief and post-traumatic growth after an earthquake, are there similar evidence-based therapies or programs available to me right now?
3The trial measures 'psychological resilience' as its main outcome — what does that actually mean in practice, and how would we know if a grief therapy is working well for my specific situation?
4Since this study focuses on both traumatic grief and what they call 'existential grief,' can you help me understand which type of grief might be most relevant to what I'm going through, and whether that changes what kind of support I should be seeking?
5Given that this is a Phase NA study focused on therapy rather than a drug, what should I know about the current state of the evidence for grief-focused interventions for PTSD and bereavement — and are there established guidelines you'd recommend following in the meantime?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.